TY - JOUR
T1 - Increased frequency of disease-causing MYH mutations in colon cancer families
AU - Peterlongo, Paolo
AU - Mitra, Nandita
AU - de Abajo, Ana Sanchez
AU - de la Hoya, Miguel
AU - Bassi, Chiara
AU - Bertario, Lucio
AU - Radice, Paolo
AU - Glogowski, Emily
AU - Nafa, Khedoudja
AU - Caldes, Trinidad
AU - Offit, Kenneth
AU - Ellis, Nathan A.
N1 - Funding Information:
The authors are grateful to Gabriel Lerman for his technical assistance, to Dr Peter Gregersen, who provided DNAs from healthy New York controls through the New York Cancer Project, and to Dr Fernando Ravagnani, who provided blood samples from healthy Italian controls. This work was supported by the National Institutes of Health grants CA103500 (to N.A.E.) and CA103394 (to N.M.), by a fellowship from the Cancer Research and Prevention Foundation (to P.P.), by a grant from Bristol-Myers Squibb C03/ 10 RTICCC, FIS 04/0957 (to T.C.) and by grants from the Italian Association for Cancer Research and the Italian Foundation for Cancer Research (to L.B. and P.R). This study was supported by the Kate and Robert Niehaus Foundation for cancer research; additional support was provided by the Byrne Foundation, the Sloan-Kettering Institute, and the Academic Medicine Development Company.
PY - 2006/11/15
Y1 - 2006/11/15
N2 - The genetic factors that cause clustering of colorectal cancers (CRCs) other than mutations in the mismatch repair (MMR) genes are not well understood. Clustering in families who lack MMR gene mutations may be attributable to low-penetrance mutations. Hypothetically, mono-allelic MYH mutations could contribute to the risk of CRC in these families. Using Fisher's exact test and logistic regression, we compared the frequency of the known disease-causing MYH mutations Y165C, G382D and 466delE in 137 probands (117 cases with CRC and 20 cases diagnosed on the basis of adenomatous polyps only) from families with three or more CRCs but negative for mutations in the MMR genes and in 967 healthy controls with comparable ethnic backgrounds. Of 137 cases, 6 (4.4%) carried mono-allelic MYH mutations compared with 16 of 967 (1.6%) controls. In addition, three bi-allelic MYH mutation carriers, who eventually developed MYH-associated polyposis, were also identified in families with pedigree structures consistent with dominant inheritance of CRC susceptibility. By Fisher's exact tests, there was a statistically different frequency of cases with any MYH mutation (mono- or bi-allelic carriers; P-value = 0.002) and of cases with mono-allelic MYH mutation (P = 0.04) compared with the controls. Using a logistic regression model, the unadjusted odds ratio associated with any MYH mutation was 4.14 (P-value < 0.001); for mono-allelic carriers, it was 2.79 (P-value = 0.04). Adjusting for ethnic backgrounds, gender and age, the odds ratio associated with any disease-causing MYH mutation was 3.23 (P-value = 0.01); for mono-allelic carriers, it was 1.99 (P-value = 0.20). Overall, the results support previous studies suggesting that mono-allelic mutations of MYH constitute low-penetrance CRC-causing alleles. These data further support a model in which low-penetrance alleles are enriched in MMR gene mutation-negative CRC families.
AB - The genetic factors that cause clustering of colorectal cancers (CRCs) other than mutations in the mismatch repair (MMR) genes are not well understood. Clustering in families who lack MMR gene mutations may be attributable to low-penetrance mutations. Hypothetically, mono-allelic MYH mutations could contribute to the risk of CRC in these families. Using Fisher's exact test and logistic regression, we compared the frequency of the known disease-causing MYH mutations Y165C, G382D and 466delE in 137 probands (117 cases with CRC and 20 cases diagnosed on the basis of adenomatous polyps only) from families with three or more CRCs but negative for mutations in the MMR genes and in 967 healthy controls with comparable ethnic backgrounds. Of 137 cases, 6 (4.4%) carried mono-allelic MYH mutations compared with 16 of 967 (1.6%) controls. In addition, three bi-allelic MYH mutation carriers, who eventually developed MYH-associated polyposis, were also identified in families with pedigree structures consistent with dominant inheritance of CRC susceptibility. By Fisher's exact tests, there was a statistically different frequency of cases with any MYH mutation (mono- or bi-allelic carriers; P-value = 0.002) and of cases with mono-allelic MYH mutation (P = 0.04) compared with the controls. Using a logistic regression model, the unadjusted odds ratio associated with any MYH mutation was 4.14 (P-value < 0.001); for mono-allelic carriers, it was 2.79 (P-value = 0.04). Adjusting for ethnic backgrounds, gender and age, the odds ratio associated with any disease-causing MYH mutation was 3.23 (P-value = 0.01); for mono-allelic carriers, it was 1.99 (P-value = 0.20). Overall, the results support previous studies suggesting that mono-allelic mutations of MYH constitute low-penetrance CRC-causing alleles. These data further support a model in which low-penetrance alleles are enriched in MMR gene mutation-negative CRC families.
UR - http://www.scopus.com/inward/record.url?scp=33750460975&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33750460975&partnerID=8YFLogxK
U2 - 10.1093/carcin/bgl093
DO - 10.1093/carcin/bgl093
M3 - Article
C2 - 16774938
AN - SCOPUS:33750460975
SN - 0143-3334
VL - 27
SP - 2243
EP - 2249
JO - Carcinogenesis
JF - Carcinogenesis
IS - 11
ER -